Drawing for HEALTH ALL IN ONE

USPTO serial 50031173

HEALTH ALL IN ONE

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
RENNEKER, CHRISTOPHER JOHN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HEALTH ALL IN ONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Erich G. Rhynhart

Erich G. Rhynhart CVS Pharmacy, Inc.One CVS DriveMailcode: 1160Woonsocket, RI 02895

Goods and services

ClassDescriptionStatusFirst use
038Electronic message transmission; providing online forums for transmission of messages among computer users concerning health, wellness, healthcare, medical services, insurance, prescriptions, and pharmacy information and services; telecommunication services, namely, providing electronic message alerts via the internet; providing online chat rooms and bulletin boards for transmission of messages among computer users in the field of health, wellness, healthcare, medical services, insurance, prescriptions, and pharmacy information and services; communication services, namely, transmitting, streaming, and broadcasting of text, images, audio, video and data via mobile phones, smartphones, portable electronic devices, portable digital devices, tablet computers, and computers in the field of health, wellness, healthcare, medical services, insurance, prescriptions, and pharmacy information and services; streaming of audio, visual and audiovisual material via the internet or other computer or communications network; providing access to online directories, databases, blogs, and online reference materials; providing online chat rooms, internet forums and online communitiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 3, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 30, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 30, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 30, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 3, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2026DOCKASSIGNED TO EXAMINER—
Aug 4, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 4, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 4, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance